Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Mid-range Performer

Download real time

1636.70 -2.50 (-0.15%)

36.47% Gain from 52W Low

1.2M

NSE+BSE Volume

NSE 20 Jun, 2025 3:31 PM (IST)

US FDA Observation

Glenmark Pharma gets Form 483 with five observations from the US FDA for its USA formulations unit See details

Glenmark Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Glenmark Pharmaceuticals Ltd. from all sources in a single place.

Is Glenmark Pharmaceuticals Ltd. worth buying?

562 Votes:

Buy 79.18%

Sell 13.7%

Hold 7.12%

RESEARCH REPORTS

Buy SEE REPORTS >

Accumulate SEE REPORTS >